$118 Million is the total value of Arlington Capital Management, Inc.'s 31 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IBB | New | ISHARES TRnasdq biotec etf | $15,118,000 | – | 49,836 | +100.0% | 12.79% | – |
| IYT | New | ISHARES TRtrans avg etf | $12,694,000 | – | 77,367 | +100.0% | 10.74% | – |
| IHF | New | ISHARESus hlthcr pr etf | $12,078,000 | – | 102,039 | +100.0% | 10.22% | – |
| INDY | New | ISHARESindia 50 etf | $11,577,000 | – | 387,192 | +100.0% | 9.80% | – |
| ASHR | New | DBX ETF TRdbxtr har cs 300 | $7,763,000 | – | 208,635 | +100.0% | 6.57% | – |
| LUV | New | SOUTHWEST AIRLS CO | $7,580,000 | – | 179,105 | +100.0% | 6.42% | – |
| LB | New | L BRANDS INC | $7,424,000 | – | 85,782 | +100.0% | 6.28% | – |
| ULTA | New | ULTA SALON COSMETCS & FRAG I | $6,553,000 | – | 51,257 | +100.0% | 5.55% | – |
| FXI | New | ISHARES TRchina lg-cap etf | $6,107,000 | – | 146,741 | +100.0% | 5.17% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $3,035,000 | – | 25,544 | +100.0% | 2.57% | – |
| CELG | New | CELGENE CORP | $2,889,000 | – | 25,828 | +100.0% | 2.44% | – |
| XPO | New | XPO LOGISTICS INC | $2,779,000 | – | 67,970 | +100.0% | 2.35% | – |
| AMGN | New | AMGEN INC | $2,698,000 | – | 16,937 | +100.0% | 2.28% | – |
| MDVN | New | MEDIVATION INC | $2,607,000 | – | 26,177 | +100.0% | 2.21% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $2,390,000 | – | 26,439 | +100.0% | 2.02% | – |
| AMJ | New | JPMORGAN CHASE & COalerian ml etn | $2,135,000 | – | 46,469 | +100.0% | 1.81% | – |
| MPW | New | MEDICAL PPTYS TRUST INC | $1,471,000 | – | 106,752 | +100.0% | 1.24% | – |
| LUMN | New | CENTURYLINK INC | $1,362,000 | – | 34,405 | +100.0% | 1.15% | – |
| NYCB | New | NEW YORK CMNTY BANCORP INC | $1,328,000 | – | 82,998 | +100.0% | 1.12% | – |
| HTS | New | HATTERAS FINL CORP | $1,310,000 | – | 71,095 | +100.0% | 1.11% | – |
| REM | New | ISHARESmrg rl es cp etf | $1,306,000 | – | 111,535 | +100.0% | 1.10% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $1,266,000 | – | 3,086 | +100.0% | 1.07% | – |
| HPF | New | HANCOCK JOHN PFD INCOME FD I | $983,000 | – | 48,325 | +100.0% | 0.83% | – |
| BACPRL | New | BANK AMER CORP7.25%cnv pfd l | $949,000 | – | 817 | +100.0% | 0.80% | – |
| EMB | New | ISHARESjp mor em mk etf | $811,000 | – | 7,392 | +100.0% | 0.69% | – |
| PM | New | PHILIP MORRIS INTL INC | $478,000 | – | 5,867 | +100.0% | 0.40% | – |
| T | New | AT&T INC | $462,000 | – | 13,753 | +100.0% | 0.39% | – |
| SSW | New | SEASPAN CORP | $357,000 | – | 19,796 | +100.0% | 0.30% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $278,000 | – | 3,953 | +100.0% | 0.24% | – |
| EXC | New | EXELON CORP | $219,000 | – | 5,915 | +100.0% | 0.18% | – |
| EMD | New | WESTERN ASSET EMRG MKT DEBT | $160,000 | – | 10,155 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COMPANIA DE MINAS BUENAVENTU | 12 | Q3 2023 | 11.3% |
| PIMCO HIGH INCOME FD | 12 | Q3 2023 | 1.1% |
| FIRST TR SR FLOATING RATE 20 | 11 | Q3 2021 | 2.5% |
| NUVEEN EMERGING MKTS DEBT 20 | 11 | Q1 2022 | 1.4% |
| YAMANA GOLD INC | 10 | Q1 2023 | 5.5% |
| ABBVIE INC | 10 | Q3 2023 | 1.5% |
| NEUBERGER BERMAN MLP INCOME | 10 | Q1 2022 | 1.0% |
| FST TR NEW OPPORT MLP & ENE | 10 | Q4 2022 | 1.0% |
| UNITED STATES STL CORP NEW | 9 | Q1 2018 | 11.2% |
| INNOVATOR ETFS TR | 9 | Q3 2023 | 9.4% |
View Arlington Capital Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-24 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-25 |
| 13F-HR | 2023-08-24 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-04-21 |
| 13F-HR | 2022-01-31 |
View Arlington Capital Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.